Account wins

Share this article:
Galderma Laboratories has awarded agency of record for advertising and promotion for three products in the corrective and aesthetic market to Brand Pharm, a member of the Publicis Healthcare Communications Group of agencies. Two of the products – Pliaglistm (7% lidocaine/7 % tetracaine), a topical anesthetic, and Elevesstm, a cosmetic filler - are new products. The third product – Tri-Luma (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%), a treatment for melasma, a hyperpigmentation disorder - was already a Brand Pharm assignment for medical promotions. These new assignments increase the total to five products the agency's assignments with Galderma. Brand Pharm has had the agency assignment for Differin (adapalene), a prescription treatment for acne, and Metrogel (metronidazole gel, 1%), one of the leading therapies prescribed by dermatologists for rosacea.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.